Medical/Pharmaceuticals

Elekta Unity MR-Linac featured in 72 abstracts at European radiation oncology congress

MADRID, August 31, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 72 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac. The research described in the abstracts was conducted at 14 leading cancer centers worldwide, ref...

2021-08-31 14:21 1441

Harbour BioMed Reports 2021 Interim Results

CAMBRIDGE, Mass.and SUZHOU, China and ROTTERDAM, Netherlands, Aug. 31, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, reported its interim...

2021-08-31 13:47 3454

HeartCare Medical Announces 2021 Interim Results

HONG KONG, Aug. 31, 2021 /PRNewswire/ -- Shanghai HeartCare Medical Technology Corporation Limited ("HeartCare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 6609), a leading player in China's neuro-intervention market, announced its interim results for the si...

2021-08-31 13:11 3048

Digital Health Platform Doctor Anywhere Closes S$88 Million Series C Round to Deepen Southeast Asia Expansion

* The company has experienced a 500 percent growth in the business since the start of 2020. * The investment will significantly bolster DA's market leadership and its mission to transform the regional healthcare landscape through technology. SINGAPORE, Aug. 31, 2021 /PRNewswire/ -- Doctor Any...

2021-08-31 10:00 5691

InnoCare Announces Clearance by U.S. FDA of Clinical Trial of pan-TRK Inhibitor ICP-723

BEIJING, Aug. 30, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biopharmaceutical company, announced today the Investigational New Drug (IND) clearance of its second-generation pan-TRK inhibitor ICP-723 by the US Food and Drug Administration (FDA) for starting phase I cli...

2021-08-31 08:30 2302

Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows

MILAN, Aug. 31, 2021 /PRNewswire/ -- The number of solid organ transplants performed during the first wave of COVID-19 in 2020 plunged by 31% compared to the previous year, according to a new global study presented at theEuropean Society for Organ Transplantation (ESOT) Congress 2021

2021-08-31 07:01 1707

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022

1Q22 Added 19,673 New Subscribers Revenues Up 12.2% YoY to RMB315.2 Million ($48.8 Million) Gross Profit Up 12.6% YoY to RMB267.3 Million ($41.4 Million) Operating Income Up 17.3% YoY to RMB156.6 Million ($24.2 Million) Non-GAAP Operating Income Up 15.5% YoY to RMB168.5 Million ($26.1 Million) Confe...

2021-08-31 04:16 4187

Thrombosis Research Institute (TRI) Shares Six New GARFIELD-AF And RIVER Real-world Data Analyses At ESC Congress 2021

- Four GARFIELD-AF e-posters shine light on managing atrial fibrillation (AF) in patients with clinically challenging conditions and diabetes, as well as on AF trial populations - Two RIVER e-posters provide two-year outcomes data and insights on appropriate dosing and renal function in patients...

2021-08-31 03:56 1782

LifeTech Scientific Corporation Announces 2021 Interim Results

SHENZHEN, China, Aug. 31, 2021 /PRNewswire/ -- LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results. Compared with...

2021-08-31 03:46 4641

Viva Biotech Announced 2021 Interim Results

Revenue Increased by 419.5% YoY, CRO Business Income Increased by 62.5% YoY, O rderBacklog Recorded a Significant Increase of 72% Financial Highlights for the 6 months ended June 30, 2021: * Revenue amounted to RMB1,026.5 million, representing a year-on-year (YoY) increase of approximately 419...

2021-08-31 01:32 4801

Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix

SEOUL, South Korea, Aug. 30, 2021 /PRNewswire/ -- CancerRop (180400), a company specializing in precision medicine and molecular diagnostics, announced a jump start in the global vaccine hub for COVID-19 mRNA (messenger ribonucleic acid) with Hanmi Science through20 billion won worth of investmen...

2021-08-30 23:00 2989

Everest Medicines Announces Half-Year 2021 Interim Results

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-08-30 22:15 3583

Everest Medicines Announces Up to HK$100 million Share Repurchase Program

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...

2021-08-30 22:03 3040

Approval to Market Sofwave(TM) in South Korea

Key Regulatory Milestone in Company's International Growth Strategy for Unrivaled Ultrasound Technology Treating Fine Lines and Wrinkles YOQNEAM, Israel, Aug. 30, 2021 /PRNewswire/ -- Sofwave Medical LTD, today announced it has received approval from the Korean Ministry of Foods and Drug Safety ...

2021-08-30 20:30 1968

I-Mab Announces Upcoming Participation at September Conferences

SHANGHAI and GAITHERSBURG, Md., Aug. 30, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in Septem...

2021-08-30 20:00 1519

Zamst Announces Sponsorship with Wilfredo León Venero, a Polish Pro Volleyball Player

TOKYO, Aug. 30, 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., a company owning "Zamst," a brand of athletic braces and care products headquartered inTokyo, Japan, announced a global sponsorship agreement with Wilfredo León Venero, men's professional volleyball player playing for the SIR Safety Pe...

2021-08-30 14:00 2075

NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth

STATE COLLEGE, Pa., Aug. 30, 2021 /PRNewswire/ -- NeuExcell Therapeutics ( www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series Pre-A financing round. The round was led by Co-Win Ventures, joined by other institutional investors Yua...

2021-08-30 13:00 1523

Alphamab Oncology Reports 2021 Interim Results and Business Highlights

SUZHOU, China, Aug. 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK), announced the company's interim results for the six months ended on June 30, 2021, and highlighted recent progress and upcoming milestones. Dr. Ting Xu, Chairman and CEO of Alphamab Oncology, commented, "In 2021 ...

2021-08-30 10:51 3564

GeneQuantum announces Dr. Yi Xia as Senior Vice President of Statistics and Data Science

SUZHOU, China, Aug. 29, 2021 /PRNewswire/ -- GeneQuantum Healthcare, an industry leading biopharmaceutical company dedicated to next generation bioconjugate drugs through innovative intelligent ligase-dependent conjugation (iLDC) technology platform, announces the appointment of Dr.Yi Xia as Seni...

2021-08-30 10:00 1171

Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test

HONG KONG, Aug. 30, 2021 /PRNewswire/ -- PHASE Scientific announces that its  INDICAID™ COVID-19 Rapid Antigen Test (INDICAID™) has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic ofKenya on 17 August 2021. The authorization enables the test to be used in Ken...

2021-08-30 09:00 3483
1 ... 346347348349350351352 ... 576